Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia

Research output: Contribution to journalArticle

Standard

Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. / Hsueh, PR; Hawkey, Peter.

In: International Journal of Antimicrobial Agents, Vol. 30, No. 2, 01.08.2007, p. 129-33.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{1ad67f313b464cea9dd6633f46c20342,
title = "Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia",
abstract = "The selection of antimicrobial agents in the 2006 Guidelines (consensus statement) on Empiric Therapy for Complicated Intra-Abdominal Infections (IAIs) in Asia was based on resistance and epidemiological data from the Asian region. In these 2006 guidelines, single agent therapy using the beta-lactam/beta-lactamase inhibitors ampicillin/sulbactam or cefoperazone-sulbactam is recommended for mild-to-moderate cases, while piperacillin-tazobactam is recommended for high-severity cases. When using carbapenems, ertapenem is recommended for mild-to-moderate cases, while imipenem and meropenem are recommended for high-severity cases. For combination regimes, two types of agents are recommended: cephalosporin-based and monobactam-based. For mild-to-moderate cases, a third generation cephalosporin plus metronidazole is recommended. For high-severity cases, a third or fourth generation cephalosporin plus metronidazole+/-amikacin is recommended. For the monobactam-based regimen, aztreonam plus metronidazole is recommended for high-severity cases only.",
keywords = "intra-abdominal infections, consensus, Asia, antimicrobial therapy",
author = "PR Hsueh and Peter Hawkey",
year = "2007",
month = aug,
day = "1",
doi = "10.1016/j.ijantimicag.2007.03.002",
language = "English",
volume = "30",
pages = "129--33",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia

AU - Hsueh, PR

AU - Hawkey, Peter

PY - 2007/8/1

Y1 - 2007/8/1

N2 - The selection of antimicrobial agents in the 2006 Guidelines (consensus statement) on Empiric Therapy for Complicated Intra-Abdominal Infections (IAIs) in Asia was based on resistance and epidemiological data from the Asian region. In these 2006 guidelines, single agent therapy using the beta-lactam/beta-lactamase inhibitors ampicillin/sulbactam or cefoperazone-sulbactam is recommended for mild-to-moderate cases, while piperacillin-tazobactam is recommended for high-severity cases. When using carbapenems, ertapenem is recommended for mild-to-moderate cases, while imipenem and meropenem are recommended for high-severity cases. For combination regimes, two types of agents are recommended: cephalosporin-based and monobactam-based. For mild-to-moderate cases, a third generation cephalosporin plus metronidazole is recommended. For high-severity cases, a third or fourth generation cephalosporin plus metronidazole+/-amikacin is recommended. For the monobactam-based regimen, aztreonam plus metronidazole is recommended for high-severity cases only.

AB - The selection of antimicrobial agents in the 2006 Guidelines (consensus statement) on Empiric Therapy for Complicated Intra-Abdominal Infections (IAIs) in Asia was based on resistance and epidemiological data from the Asian region. In these 2006 guidelines, single agent therapy using the beta-lactam/beta-lactamase inhibitors ampicillin/sulbactam or cefoperazone-sulbactam is recommended for mild-to-moderate cases, while piperacillin-tazobactam is recommended for high-severity cases. When using carbapenems, ertapenem is recommended for mild-to-moderate cases, while imipenem and meropenem are recommended for high-severity cases. For combination regimes, two types of agents are recommended: cephalosporin-based and monobactam-based. For mild-to-moderate cases, a third generation cephalosporin plus metronidazole is recommended. For high-severity cases, a third or fourth generation cephalosporin plus metronidazole+/-amikacin is recommended. For the monobactam-based regimen, aztreonam plus metronidazole is recommended for high-severity cases only.

KW - intra-abdominal infections

KW - consensus

KW - Asia

KW - antimicrobial therapy

U2 - 10.1016/j.ijantimicag.2007.03.002

DO - 10.1016/j.ijantimicag.2007.03.002

M3 - Article

C2 - 17467246

VL - 30

SP - 129

EP - 133

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -